Verdad y denotación /

Por Martin, Richard M.
Publicado em c196

Electronic structure basic theory and practical methods /

Por Martin, Richard M.
Publicado em 2020

A clinical model for decision-making

Por Martin, Richard M
Publicado em 1978

Prostate cancer is omnipresent, but should we screen for it?

Por Martin, Richard M
Publicado em 2007

Did intense adverse media publicity impact on prescribing of paroxetine and the notification of suspected adverse drug reactions? Analysis of routine databases, 2001–2004

Por Martin, Richard M, May, Margaret, Gunnell, David
Publicado em 2006

Mendelian randomisation analysis of circulating adipokines and C‐reactive protein on breast cancer risk

Por Robinson, Timothy, Martin, Richard M., Yarmolinsky, James
Publicado no Int J Cancer (2020)

The incidence of adverse events and risk factors for upper gastrointestinal disorders associated with meloxicam use amongst 19 087 patients in general practice in England: cohort s...

Por Martin, Richard M, Biswas, Pipasha, Mann, Ronald D
Publicado em 2000

Does current evidence justify prostate cancer screening?

Por Martin, Richard M, Smith, George Davey, Donovan, Jenny
Publicado em 2005

The effect of pre-diagnostic vitamin D supplementation on cancer survival in women: a cohort study within the UK Clinical Practice Research Datalink

Por Jeffreys, Mona, Redaniel, Maria Theresa, Martin, Richard M.
Publicado no BMC Cancer (2015)

Predicting prostate cancer progression: protocol for a retrospective cohort study to identify prognostic factors for prostate cancer outcomes using routine primary care data

Por Merriel, Samuel W D, May, Margaret T, Martin, Richard M
Publicado no BMJ Open (2018)

Lessons from the withdrawal of rofecoxib: Patients would be safer if drug companies disclosed adverse events before licensing

Por Dieppe, Paul A, Ebrahim, Shah, Martin, Richard M, Jüni, Peter
Publicado em 2004

The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies

Por Martin, Richard M, Dunn, Nicholas R, Freemantle, Shayne, Shakir, Saad
Publicado em 2000

Breast feeding in infancy and social mobility: 60‐year follow‐up of the Boyd Orr cohort

Por Martin, Richard M, Goodall, Sarah H, Gunnell, David, Smith, George Davey
Publicado em 2007

Underreporting of suspected adverse drug reactions to newly marketed (“black triangle”) drugs in general practice: observational study

Por Martin, Richard M, Kapoor, Karan V, Wilton, Lynda V, Mann, Ronald D
Publicado em 1998

The population impact on incidence of suicide and non-fatal self harm of regulatory action against the use of selective serotonin reuptake inhibitors in under 18s in the United Kin...

Por Wheeler, Benedict W, Gunnell, David, Metcalfe, Chris, Stephens, Peter, Martin, Richard M
Publicado em 2008

Population impact of regulatory activity restricting prescribing of COX-2 inhibitors: ecological study

Por Wheeler, Benedict W, Metcalfe, Chris, Gunnell, David, Stephens, Peter, Martin, Richard M
Publicado em 2009

Association of fascin-1 with mortality, disease progression and metastasis in carcinomas: a systematic review and meta-analysis

Por Tan, Vanessa Y, Lewis, Sarah J, Adams, Josephine C, Martin, Richard M
Publicado em 2013

“Let’s get the best quality research we can”: public awareness and acceptance of consent to use existing data in health research: a systematic review and qualitative study

Por Hill, Elizabeth M, Turner, Emma L, Martin, Richard M, Donovan, Jenny L
Publicado em 2013

Reporting of drug induced depression and fatal and non-fatal suicidal behaviour in the UK from 1998 to 2011

Por Thomas, Kyla H, Martin, Richard M, Potokar, John, Pirmohamed, Munir, Gunnell, David
Publicado em 2014

Time from diagnosis to surgery and prostate cancer survival: a retrospective cohort study

Por Redaniel, Maria Theresa, Martin, Richard M, Gillatt, David, Wade, Julia, Jeffreys, Mona
Publicado no BMC Cancer (2013)